| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
| 04/10/2002 | EP1195605A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195604A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195435A1 Truncated phosphodiesterase-7 polypeptides |
| 04/10/2002 | EP1195384A1 Snake proteins having antithrombotic activity |
| 04/10/2002 | EP1195377A1 Diesters of maleic or fumaric acid |
| 04/10/2002 | EP1195158A1 Sprayable pharmaceutical compositions and device |
| 04/10/2002 | EP1194590A2 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
| 04/10/2002 | EP1194584A1 Method for producing oligopolysaccharides |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194567A1 Production of complex carbohydrates |
| 04/10/2002 | EP1194560A2 Antigenic neisserial peptides |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194443A1 Cysteinyl protease inhibitors |
| 04/10/2002 | EP1194441A2 Thiophene a2a receptor agonists |
| 04/10/2002 | EP1194425A1 Substituted benzimidazole |
| 04/10/2002 | EP1194411A1 Benzoylpyridazines |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194401A1 Diacylhydrazine derivatives |
| 04/10/2002 | EP1194172A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194157A1 D-form polypeptide which induces immune tolerance and methods of use |
| 04/10/2002 | EP1194152A1 Src kinase inhibitor compounds |
| 04/10/2002 | EP1194151A1 Integrin receptor antagonists |
| 04/10/2002 | EP1194142A1 Salts of cis -4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate! |
| 04/10/2002 | EP1194109A1 Topical formulations comprising skin penetration agents and the use thereof |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0771191B1 Immunological activity of rhamnolipids |
| 04/10/2002 | EP0758900B1 Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN |
| 04/10/2002 | EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom |
| 04/10/2002 | EP0739338B1 serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344275A Methods for amyloid removal using anti-amyloid antibodies |
| 04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344266A Novel compounds |
| 04/10/2002 | CN1344264A Tetrahydropyran derivatives and their use as therapeutic agents |
| 04/10/2002 | CN1344249A 酰胺衍生物 Amide derivatives |
| 04/10/2002 | CN1344245A Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 04/10/2002 | CN1344162A Medical compsns. |
| 04/10/2002 | CN1344159A Combinations for treatment of diseases involving angiogenesis |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1344152A Resorcinol compsn. |
| 04/10/2002 | CN1343522A Radioactive macroaggregate and its prepn. method |
| 04/10/2002 | CN1343521A Preparing box for polysaccharide compounding substance |
| 04/10/2002 | CN1343511A Exterior-applied medical salt for treating rheumatism |
| 04/10/2002 | CN1343498A 'Zhuhong San' prescription |
| 04/10/2002 | CN1343491A Method for localized anesthesia and analgesia |
| 04/10/2002 | CN1343490A Sophoridine and its application in analgesic |
| 04/10/2002 | CN1082378C Externally-used arthralgia treating medicine and its prepn. method |
| 04/09/2002 | US6369229 Pyridylalanine derivatives |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369198 Signal transducer and activator of transcription (stat) proteins; |
| 04/09/2002 | US6369193 Contulakin-G, analogs thereof and uses therefor |
| 04/09/2002 | US6369116 Composition and method for treating glaucoma |
| 04/09/2002 | US6369107 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 04/09/2002 | US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation |
| 04/09/2002 | US6369094 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl )-1h-indole, analgesic for migrane |
| 04/09/2002 | US6369089 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369077 Protease inhibitors |
| 04/09/2002 | US6369059 Tetracyclic derivatives, process of preparation and use |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368624 Homogenizing, cooling leaves, freeze drying |
| 04/09/2002 | US6368618 Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
| 04/09/2002 | US6368616 Aqueous suspension for nasal administration of loteprednol |
| 04/09/2002 | CA2171675C Aromatic heterocyclic compounds; pharmaceutical and cosmetic compositions containing the same and their uses |
| 04/09/2002 | CA2068349C Rapamycin metabolites |
| 04/09/2002 | CA2046069C Treatment of inflammatory diseases with 15-keto-prostaglandin compounds |
| 04/06/2002 | CA2358179A1 Anti-inflammatory vectors |
| 04/04/2002 | WO2002027318A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | WO2002026982A2 Secreted human proteins |
| 04/04/2002 | WO2002026954A2 Truncated phosphodiesterase-7 polypeptides |
| 04/04/2002 | WO2002026950A2 Transferases |
| 04/04/2002 | WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | WO2002026946A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/04/2002 | WO2002026935A2 TGF-β INHIBITORS AND METHODS |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026781A2 Ige receptor antagonists |
| 04/04/2002 | WO2002026746A2 1-oxorapamycins |
| 04/04/2002 | WO2002026738A1 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN |
| 04/04/2002 | WO2002026733A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026722A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026711A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 04/04/2002 | WO2002026708A1 Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient |
| 04/04/2002 | WO2002026694A1 O-substituted 6-methyl-tramadol derivatives |
| 04/04/2002 | WO2002026279A1 E-ptfe foil impregnated with an encapsulated bioactive substance |
| 04/04/2002 | WO2002026265A2 Pegylated interleukin-10 |